Continuous Blood Glucose Monitoring Market Outlook Signals Expansion To $26.11 Billion Through 2030

The continuous blood glucose monitoring market is on the cusp of significant expansion, driven by technological advancements and increasing demand for effective diabetes management tools. This sector is evolving rapidly with innovations that enhance patient convenience and offer more precise glucose tracking. Below is an overview of the market size projections, key players, emerging trends, and segment-wise outlook that define the current and future landscape of continuous blood glucose monitoring.

Projected Growth Trajectory of the Continuous Blood Glucose Monitoring Market
The continuous blood glucose monitoring industry is set for robust growth in the coming years. Forecasts indicate that the market will reach $26.11 billion by 2030, growing at a compound annual growth rate (CAGR) of 12.5%. This expansion is largely fueled by progress in implantable and flash glucose sensor technologies, the rise of homecare and remote monitoring solutions, the integration of devices with digital health platforms, heightened awareness about diabetes self-management, and the adoption of AI-driven predictive analytics. Anticipated trends during this period include increasing use of continuous glucose monitoring systems, enhanced connectivity with smartphone applications and wearable devices, growth in home-based diagnostic services for diabetes, development of minimally invasive and implantable sensors, and a stronger emphasis on real-time data analysis and alert systems.

Download a free sample of the continuous blood glucose monitoring market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13079&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Leading Companies Driving the Continuous Blood Glucose Monitoring Market
The market features a competitive landscape with several prominent players, including F. Hoffmann-La Roche Ltd., Medtronic plc., Abbott Laboratories, GlySens Inc., Senseonics Holdings Inc., Glysure Limited, Nemaura Medical Inc., Tandem Diabetes Care Inc., Ypsomed Holding AG, Orsense Ltd., Dexcom Inc., Insulet Corporation, Medtrum Technologies Inc., Beta Bionics Inc., Bigfoot Biomedical Inc., GluSense Ltd., i-SENS Inc., Osang Healthcare Co Ltd., WaveForm Technologies, EyeSense GmbH, Calisto Medical, Biorasis, DirectSens GmbH, and Ultrahuman Healthcare. In a recent strategic move, Medtronic plc., based in Ireland, acquired EOFlow in May 2023. This acquisition aims to broaden Medtronic's diabetes care portfolio and strengthen its ability to support a wider global population managing diabetes through an integrated Medtronic ecosystem. EOFlow, headquartered in South Korea, is known for producing the insulin patch pump EOPatch.

Emerging Innovations Shaping the Future of Continuous Blood Glucose Monitoring
Key industry players are focusing heavily on developing next-generation continuous glucose monitoring systems designed to provide real-time glucose data, boost patient ease of use, and improve overall diabetes care outcomes. A CGM system continuously monitors glucose levels throughout the day and night, delivering frequent real-time updates. For example, in August 2025, Abbott Laboratories introduced the FreeStyle Libre 2 Plus system in the US market. This sophisticated CGM sensor provides continuous glucose readings every minute directly to compatible smartphones without requiring manual scans. It also features optional alarms for low and high glucose levels, supports 15 days of wear, and integrates seamlessly with Abbott's digital health platforms like LibreView and LibreLink Up. This innovation aims to enhance glycemic control, minimize hypoglycemia risk, and offer actionable insights, all while eliminating the need for routine finger-pricking.

View the full continuous blood glucose monitoring market report:
https://www.thebusinessresearchcompany.com/report/continuous-blood-glucose-monitoring-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Segment Analysis and Market Share Outlook in the Continuous Blood Glucose Monitoring Industry
The continuous blood glucose monitoring market is analyzed across multiple segments to provide detailed insights:
1) By Component: Insulin Pumps, Sensors, Transmitters, Receivers
2) By Application: Type 1 Diabetic Patients, Type 2 Diabetic Patients, Gestational Diabetes, Critical Care Patients
3) By End User: Hospitals, Homecare Diagnostics, Other End Users
Further breakdown of subsegments includes:
- Insulin Pumps: Tubeless Insulin Pumps, Tubed Insulin Pumps, Patch Pumps
- Sensors: Continuous Glucose Monitoring Sensors, Flash Glucose Monitoring Sensors, Implantable Sensors
- Transmitters: Integrated Transmitters, Wireless Transmitters, Bluetooth-Enabled Transmitters
- Receivers: Standalone Receivers, Smartphone Apps, Integrated Devices

This detailed segmentation helps stakeholders understand market dynamics and tailor solutions for diverse patient needs and user environments.

Expanded capabilities in our 2026 market reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.